Imipridone ONC201: combination therapy in hematologic malignancies

Ajai Chari; Bart Barlogie

doi:10.1080/15384101.2018.1490861

Imipridone ONC201: combination therapy in hematologic malignancies

Ajai Chari, Bart Barlogie

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	1947-1948
Number of pages	2
Journal	Cell Cycle
Volume	17
Issue number	16
DOIs	https://doi.org/10.1080/15384101.2018.1490861
State	Published - 2018

Keywords

ONC201
imipridone
leukemia
lymphoma
multiple myeloma

Access to Document

10.1080/15384101.2018.1490861

Cite this

@article{fdf8ab007eea4aed92069eef897a2d16,

title = "Imipridone ONC201: combination therapy in hematologic malignancies",

keywords = "ONC201, imipridone, leukemia, lymphoma, multiple myeloma",

author = "Ajai Chari and Bart Barlogie",

year = "2018",

doi = "10.1080/15384101.2018.1490861",

language = "English",

volume = "17",

pages = "1947--1948",

journal = "Cell Cycle",

issn = "1538-4101",

publisher = "Landes Bioscience",

number = "16",

}

TY - JOUR

T1 - Imipridone ONC201

T2 - combination therapy in hematologic malignancies

AU - Chari, Ajai

AU - Barlogie, Bart

PY - 2018

Y1 - 2018

KW - ONC201

KW - imipridone

KW - leukemia

KW - lymphoma

KW - multiple myeloma

UR - http://www.scopus.com/inward/record.url?scp=85054772025&partnerID=8YFLogxK

U2 - 10.1080/15384101.2018.1490861

DO - 10.1080/15384101.2018.1490861

M3 - Comment/debate

C2 - 29929441

AN - SCOPUS:85054772025

SN - 1538-4101

VL - 17

SP - 1947

EP - 1948

JO - Cell Cycle

JF - Cell Cycle

IS - 16

ER -